Abstract | BACKGROUND: METHODS: Sixty vitamin E-deficient children with chronic cholestasis unresponsive to 70-212 IU.kg-1.day-1 of oral vitamin E were entered into a trial at eight centers in the United States. After initial evaluation, treatment was started with 25 IU.kg-1.day-1 of TPGS. Vitamin E status, neurological function quantitated by a specific scoring system, and clinical and biochemical parameters were monitored during therapy. RESULTS: All children responded to TPGS with normalization of vitamin E status. Neurological function, which had deteriorated before entry in the trial, improved in 25 patients, stabilized in 27, and worsened in only 2 after a mean of 2.5 years of therapy. No adverse effects were observed. CONCLUSIONS:
|
Authors | R J Sokol, N Butler-Simon, C Conner, J E Heubi, F R Sinatra, F J Suchy, M B Heyman, J Perrault, R J Rothbaum, J Levy |
Journal | Gastroenterology
(Gastroenterology)
Vol. 104
Issue 6
Pg. 1727-35
(Jun 1993)
ISSN: 0016-5085 [Print] United States |
PMID | 8500733
(Publication Type: Clinical Trial, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Vitamin E
- Polyethylene Glycols
- Copper
- tocophersolan
|
Topics |
- Adolescent
- Adult
- Age Factors
- Child
- Child, Preschool
- Cholestasis
(complications, drug therapy)
- Chronic Disease
- Copper
(blood)
- Female
- Humans
- Infant
- Male
- Polyethylene Glycols
- Stereoisomerism
- Vitamin E
(administration & dosage, analogs & derivatives, therapeutic use)
- Vitamin E Deficiency
(complications, drug therapy)
|